This inventor holds 1 USPTO granted patent. Top assignee: Nippon Chemiphar Co., Ltd.. Active years: 1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984
Title: Kaname Kondo: Innovator in Pharmaceutical Chemistry
Introduction
Kaname Kondo is a notable inventor based in Koshigaya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on chemical compounds. His research focuses on developing compounds that have therapeutic applications, particularly in the area of inflammation and allergic reactions.
Latest Patents
Kaname Kondo holds a patent for "Amidinopiperidine derivatives." This compound is characterized by a specific formula where R can represent various groups, including hydrogen, naphthyl, indanyl, and others. The compound is designed to inhibit complement reactions, inflammation caused by allergic reactions, and platelet aggregation. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Kondo is associated with Nippon Chemiphar Co., Ltd., where he continues to engage in research and development. His work has been instrumental in creating compounds that are not only innovative but also have practical applications in medicine. His dedication to his field has earned him recognition among his peers.
Collaborations
Throughout his career, Kaname Kondo has collaborated with esteemed colleagues such as Yoshio Kikawa and Hiroyasu Sekine. These collaborations have further enriched his research and contributed to the development of new pharmaceutical solutions.
Conclusion
Kaname Kondo's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His work on Amidinopiperidine derivatives highlights the importance of research in addressing health challenges. His ongoing efforts continue to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile